Form 10-Q TETRAPHASE PHARMACEUTICA For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tetraph Pharma (TTPH) Misses Q2 EPS by 17c
August 12, 2014 4:44 PM EDTTetraph Pharma (NASDAQ: TTPH) reported Q2 EPS of ($0.71), $0.17 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $2.79 million.
For earnings history and earnings-related data on Tetraph Pharma (TTPH) click here.
... More


